# A Study of Herceptin (Trastuzumab) in Combination Chemotherapy in Women With Locally Advanced Breast Cancer

> **NCT01998906** · PHASE3 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 330 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Trastuzumab
- **DRUG:** Doxorubicin
- **DRUG:** Paclitaxel
- **DRUG:** CMF

## Key facts

- **NCT ID:** NCT01998906
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-05
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 330 (ACTUAL)
- **Last updated:** 2014-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01998906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01998906, "A Study of Herceptin (Trastuzumab) in Combination Chemotherapy in Women With Locally Advanced Breast Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01998906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*